EBITDA Margin % is calculated as EBITDA divided by its Revenue. Ercros's EBITDA for the
three
months ended in Mar. 2026 was €-1.0 Mil. Ercros's Revenue for the
three
months ended in Mar. 2026 was €150.1 Mil. Therefore, Ercros's EBITDA margin for the quarter that ended in Mar. 2026 was -0.69%.
Ercros (CHIX:ECRe) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Ercros EBITDA Margin % Related Terms
Ercros EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Ercros's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Ercros's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ercros EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Ercros's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Ercros's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ercros (CHIX:ECRE) has a EBITDA Margin % of -0.69% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ercros and its competitors. According to the industry distribution chart, Ercros ranks #1312 out of 1584 companies in the Chemicals industry, placing it in the top 82.8%.
Is Ercros' EBITDA Margin % too high?
Ercros' current EBITDA Margin % is -0.69%. Based on the distribution chart, Ercros ranks #1312 out of 1584 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Ercros has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Ercros' EBITDA Margin % compare to DOW?
According to the Chemicals industry distribution chart, Ercros ranks #1312 out of 1584 companies for EBITDA Margin %. This places Ercros in the lower half of its industry. The industry median EBITDA Margin % is 9.64. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,584 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ercros and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ercros's current EBITDA Margin % is -0.69%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ercros stock overvalued right now?
Ercros (CHIX:ECRE) has a current EBITDA Margin % of -0.69%. The stock's GF Value™ is €2.93, compared to a current price of €3.40 — trading 15.9% above its estimated fair value. The current EBITDA Margin % is -0.69%. Ercros' overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Ercros (CHIX:ECRE), the current EBITDA Margin % is -0.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ercros (CHIX:ECRE) Overvalued in 2026?
Based on GuruFocus' analysis, Ercros stock appears to be overvalued.
The current stock price of €3.40 is trading 15.9% above its estimated GF Value™ of €2.93.
Key valuation signals for CHIX:ECRE:
EBITDA Margin %: -0.69%
GF Value™: €2.93 vs. price of €3.40 (15.9% above fair value)
No single metric tells the full story. See the CHIX:ECRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ercros SA is a chemical manufacturing company operating in basic and plastic chemicals divisions, intermediate chemicals division, and pharmaceuticals division. The company's product portfolio includes Caustic soda, Hydrochloric acid, Sodium chloride, Sodium hypochlorite, Glues and resins, Moulding compounds, Pentaerythritol, Erythromycin, Fosfomycin, Fusidic acid, among others. Its products are supplied to various industries including the chemical industry, construction, wood industry, paints, food industry, pharmaceuticals, electric material, and water treatment. The majority of the revenue is derived from the sale of basic chemicals in the local markets.
73GF Score
Get the complete analysis for CHIX:ECRE
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:ECRE has been successfully added to your 
